Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of VX-993 in treating acute pain after a bunionectomy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vertex Pharmaceuticals Incorporated
NCT07290881 · Acute Pain
NCT06779604 · Post Operative Pain, Anesthesia, and more
NCT07422272 · Pain Threshold, Pain Tolerance, and more
NCT07310953 · Analgesia, Post Operative Pain, and more
NCT06184126 · Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease, and more
Shoals Medical Trials Inc.
Sheffield, Alabama
Arizona Research Center
Phoenix, Arizona
Woodland International Research Group
Little Rock, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions